So Many Guidelines, So Little Time:

Slides:



Advertisements
Similar presentations
Where Are We on the Path to Elimination of Chronic Hepatitis C?
Advertisements

Acute Hypertension Management Optimizing Door-to-Needle Time in Ischemic Stroke.
Optimizing Outcomes in Short Bowel Syndrome With IF
Risk Stratification in PAH: What Do the Latest Data Suggest?
A Paradigm Shift in PAH.
HCV: Who Should We Screen and Why?
Cardiogenic Shock.
The Clinical Enigma of Cardiogenic Shock
The Nurse View.
Introduction ESC Annual Meeting in Review: NOACs and NVAF: Real-World Data, Guidelines, and More.
Patient Case Discussions in T2D: What Intensification Plan Is Best?
Lessons for early pregnancy care
Ask the Onychomycosis Expert, Part 2
The Latest Data on Oral Prostacyclin Therapy in PAH
What Comes Second?.
Stopping the Epidemic HIV Prevention Today
Program Goals. Implementing the Updated American Thyroid Association Guidelines and Recommendations for RAI-R DTC.
American Heart Association Scientific Sessions
Managing Hereditary Angioedema
Individualizing Prophylaxis in Hemophilia
Hot Topics in Hemophilia Nursing
Program Goal. Program Goal Current Stroke Guidelines: AHA/ASA.
Chronic Idiopathic Urticaria
The Essentials for Secondary Stroke Prevention
Tailoring Hemophilia Prophylaxis Therapy
Anticoagulation Therapy in Patients Post-TAVR
Counseling Patients About Germline BRCA Mutations
Improving Narcolepsy Diagnosis
Case Study. Managing Medication and Adherence in SIHD: Partnering With the Patient to Improve Care.
Are We Closer to Personalized Medicine in MS?
Overview. Maximizing the Safety of CAR T-Cell Therapy: Prevention, Early Recognition, and Management.
Seizures in the Elderly: Treatment and Special Considerations
Rheumatoid Arthritis 2015 Guidelines What's New? What's Different?
Avoiding Opioid Overuse: Guideline-Based Management of Osteoarthritis
A Better Solution For Cancer Patients With VTE?
Program Goals. Implementing the Updated American Thyroid Association Guidelines and Recommendations for RAI-R DTC.
Optimizing Frontline Care for Older Patients With Multiple Myeloma
The Importance of Getting the Dose Right in HF
Atrial Fibrillation.
A Roadmap to Diagnosing the Next Patient With Hereditary Angioedema
Best Practices in the Identification and Management of Alzheimer Agitation.
Oral Prostanoids and PAH
Multidisciplinary Approaches to Managing Hemophilia
Prophylaxis Strategies in Hereditary Angioedema Weighing the Evidence
Maintenance Therapy in Advanced Ovarian Cancer
When to Start and What to Use
The Road to Quality Improvement in HER2-Positive Breast Cancer
Trials and Tribulations in VTE: How Do Real-World Data Fit In?
Prolonging the Effects of Factor IX Replacement Therapy in Hemophilia B.
Case 1 Presentation Case 1 (cont) Assessment and Recommendations.
Expanding the Horizons in Hereditary Angioedema
Managing HF in Primary Care
Updates on the Prevention and Management of CINV
Current Challenges in Managing Hemophilia
Iron Deficiency in Heart Failure
A Nursing Perspective on Improving Outcomes for Patients With Hemophilia.
Current Controversies and Advances in Hepatorenal Syndrome
Program Goals Background: Anticoagulation in Patients With VTE.
Treating Atypical Hemolytic Uremic Syndrome A Case Discussion
Inhaled Antibiotics for Patients With CF in the Era of CFTR Modulators
Clinical Challenges and Updates in Managing Seizure Clusters
An Appraisal of Narcolepsy Guidelines
Quality Improvement and Molecular Profiling in Advanced Non-Small Cell Lung Cancer.
Renal Function and Myeloma Therapeutics
Selecting Treatment Approaches in Hemophilia
Breaking Barriers in PAH: Role of Novel Early Treatment Strategies
Prostacyclin Pathway Agents in Action
HAE Prophylaxis.
Championing Evidence-Based Care in Patients With Acute Low Back Pain
Navigating the Journey
Presentation transcript:

So Many Guidelines, So Little Time:

Available Guidelines for HAE

Diagnosis of HAE

HAE: Laboratory Characteristics

Recommendations for On-demand Therapy

Recommendations for On-demand Therapy (cont)

Recommendations for On-demand Therapy (cont)

Recommendations for Short-term Prophylaxis

Recommendations for Long-term Prophylaxis

Recommendations for Long-term Prophylaxis (cont)

Recommendations for Children and Women

Angioedema With Normal C1-INH (Type 3)

Angioedema With Normal C1-INH (Type 3) (cont)

Angioedema With Normal C1-INH (Type 3) (cont)

Summary

Abbreviations

References

References (cont)